title: Effects of bifemelane hydrochloride on plasma neuropeptide Y, 3-methoxy-4-hydroxyphenylethylene glycol and 5-hydroxy-indole acetic acid concentrations in patients with cerebral infarction.
abstract: Bifemelane hydrochloride (BH) is widely employed in Japan in the treatment of cerebral infarction patients with depressive symptoms and its antidepressant action is considered to be caused by the normalizing effects of neurotransmitters. The relationship between the normalizing effects of neurotransmitters of BH and the depressive state of patients with cerebral infarction was examined. BH 150 mg/day was administered for three months to 13 cerebral infarction patients with depressive state. We measured the plasma neuropeptide Y (NPY), 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and 5-hydroxy-indole acetic acid (5-HIAA), and assessed the depressive symptoms using the 21-item Hamilton's Rating Scale for Depression (HRSD) before and after administration of BH. After treatment, the plasma NPY concentration was significantly increased, the plasma MHPG concentration and total score of HRSD were significantly decreased, and the plasma 5-HIAA concentration showed no changes. These findings suggest that the antidepressant effect of BH is caused by the normalizing effects of NPY and noradrenalinergic neurons.
authors.affiliation: Department of Neuropsychiatry, Osaka City University Medical School, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Koide
authors.forename: H
authors.initials: H
authors.lastname: Onishi
authors.forename: H
authors.initials: H
authors.lastname: Hashimoto
authors.forename: T
authors.initials: T
authors.lastname: Kai
authors.forename: M
authors.initials: M
authors.lastname: Katayama
authors.forename: S
authors.initials: S
authors.lastname: Yamagami
mesh_terms: D000368:Aged; D000928:Antidepressive Agents / Q000494:pharmacology*; D001559:Benzhydryl Compounds / Q000494:pharmacology*; D002544:Cerebral Infarction / Q000097:blood* / Q000523:psychology; D002851:Chromatography, High Pressure Liquid; D003863:Depression / Q000523:psychology; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000097:blood*; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000097:blood*; D008875:Middle Aged; D009478:Neuropeptide Y / Q000097:blood*; D018697:Nootropic Agents / Q000494:pharmacology*; D011569:Psychiatric Status Rating Scales; D011863:Radioimmunoassay
chemical_list: D000928:Antidepressive Agents; D001559:Benzhydryl Compounds; D009478:Neuropeptide Y; D018697:Nootropic Agents; D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid; C031906:bifemelane